COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 5 October 2017 have been made available

04/09/2017 - 07:00

Regulated information The preliminary documents for the Extraordinary General Shareholder Meeting on 5 October 2017 have been made available Gosselies, Belgium, 4 September 2017, 7am CEST - BONE THERAPEUTICS (Euronext [...]

Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 5 octobre 2017

04/09/2017 - 07:00

Information réglementée Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 5 octobre 2017 Gosselies, Belgique, le 4 septembre 2017, 7h CEST - BONE THERAPEUTICS (code Euronext [...]

Novartis annonce que son Directeur général, Joseph Jimenez, a décidé de quitter la société en 2018. Vasant Narasimhan est nommé Directeur général, à compter du 1er février 2018.

04/09/2017 - 07:00

Bâle, le 4 septembre 2017 - Joseph Jimenez, Directeur général (CEO) de Novartis, a informé le Conseil d'administration de son souhait de quitter ses fonctions de Directeur général en 2018, après avoir occupé ce poste [...]

Data Published in The Lancet Shows Positive Results at Primary Endpoint in the Treatment of Resistant Hypertension with MobiusHD Device

02/09/2017 - 00:30

Publication Follows Positive Interim Results in US and EU Patients Presented at the European Society of Cardiology Conference MOUNTAIN VIEW, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc. (VDI), a [...]

Taconic Biosciences sponsorise un modèle personnalisé pour la prise en charge du syndrome de Kabuki, une maladie rare qui entraîne un déficit intellectuel

01/09/2017 - 21:17

HUDSON, New York, le 31 août 2017 (GLOBE NEWSWIRE) - Taconic Biosciences, leader mondial en matière de modèles de rongeurs génétiquement modifiés et de services associés, finance le développement d'un modèle de souris [...]

Diaxonhit : Prise d'effet du regroupement d'actions par 20

01/09/2017 - 18:40

Prise d'effet du regroupement d'actions DIAXONHIT Modalités du regroupement d'actions: regroupement par voie d'échange à raison de 1 action nouvelle regroupée contre 20 actions anciennes Les actions nouvelles ont été [...]

FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants

01/09/2017 - 15:00

FIT Biotech Oy Company release September 1, 2017 at 4:00 pm FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On September 26, 2016, the Board of Directors of FIT Biotech Oy [...]

Shire plc : Total voting rights

01/09/2017 - 12:30

Total Voting Rights September 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]

Zealand increases its share capital as a consequence of exercise of employee warrants

01/09/2017 - 09:18

Company announcement - No. 43 / 2017 Zealand increases its share capital as a consequence of exercise of employee warrants Copenhagen, September 1, 2017 - Zealand has increased its share capital by a nominal amount of [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

01/09/2017 - 09:00

FIT Biotech Oy Company release September 1, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Changes in Amer Sports leadership team

01/09/2017 - 09:00

Amer Sports Corporation STOCK EXCHANGE RELEASE September 1, 2017 at 10:00 a.m. Changes in Amer Sports leadership team Bernard Millaud, President of Cycling and a member of Amer Sports Executive Board has decided to step [...]

Notice of extraordinary general meeting in Aino Health AB (publ.)

01/09/2017 - 08:30

The shareholders in Aino Health AB (publ) reg. no. 559063-5073 (the "Company") are hereby convened to the extraordinary general meeting on Tuesday October 3, 2017, at 05:00 p.m. at Grand Hotel, Bantorget 1, 222 29 Lund [...]

Aino Health AB (publ): proposes changes to the Board

01/09/2017 - 08:30

Aino Health AB gears its Board's expertise by nominating Liselotte Bergmark as a new Board member, to be elected at an extraordinary general meeting. Liselotte Bergmark will provide the Board with international branch [...]

Verona Pharma Appoints Stifel as Nominated Adviser

01/09/2017 - 08:00

LONDON, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

DBV Technologies to Attend Upcoming Investor Conferences

01/09/2017 - 07:30

Press Release Montrouge, France, September 1, 2017 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced that members [...]

DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs

01/09/2017 - 07:30

Communiqué de Presse Montrouge, France, 1 Septembre 2017, 7h30 CEST DBV Technologies Invitée à Présenter lors des prochaines Conférences Investisseurs DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : [...]

ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB

01/09/2017 - 07:30

Leuven, Belgium 1 September 2017 - ONCURIOUS NV, a Belgium-based biotech company focusing on the development of innovative oncology treatments, today announces that it has reached principle agreement with VIB to acquire [...]

Taconic Biosciences Sponsors Custom Model to Support Kabuki Syndrome, a Rare Disorder Causing Intellectual Disability

31/08/2017 - 23:22

HUDSON, N.Y., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered rodent models and associated services, is funding the development of a custom mouse model to study Kabuki [...]

NANOBIOTIX : Résultats semestriels au 30 juin 2017

31/08/2017 - 19:29

Résultats semestriels au 30 juin 2017 Paris, France, et Cambridge, Massachusetts (USA) le 31 août 2017 - NANOBIOTIX (Euronext : NANO - ISIN : FR0011341205), société française pionnière en nanomédecine développant de [...]